Skip to main content
Clinical Trials/NCT05610748
NCT05610748
Active, Not Recruiting
Phase 4

Implant-supported Rehabilitation of Atrophic Edentulous Sites With a Novel, Simplified Technique for Bone Augmentation or Soft Tissue Augmentation: a Randomized Trial

Università degli Studi di Ferrara1 site in 1 country66 target enrollmentJuly 1, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Dehiscence
Sponsor
Università degli Studi di Ferrara
Enrollment
66
Locations
1
Primary Endpoint
Proportion of patients free from peri-implantitis
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

The primary aim of the present study is to compare the Sub-periosteal Peri-implant Augmented Layer (SPAL) technique and soft tissue augmentation (STA), performed simultaneously to implant placement, in terms of (i) implant survival rate and (ii) health/disease condition of the peri-implant tissues at 6 and 12 months following implant loading. The secondary aim of the project will be to compare the SPAL technique and STA in terms of intra- and post-operative morbidity.

The study is designed as a single-blind, parallel-arm, randomized clinical trial. Patients will be recruited and treated at the Operative Unit of Dentistry, Azienda Unità Sanitaria Locale (A.U.S.L.) of Ferrara, Italy, and one University center (Research Centre for the Study of Periodontal and Peri-implant Diseases, University of Ferrara, Italy). Each patient will contribute the study with one sextant ("experimental sextant"). Each eligible patient will be randomly assigned to receive SPAL technique or STA according to a computer-generated randomization list. Surgical procedures will be performed by experienced periodontal and implant surgeons. Two calibrated, blinded examiners will take care of the assessment of clinical and radiographic parameters, Case Report Form (CRF) filling, as well as data extraction from CRFs for the preparation of the study database.

The proportion of patients free from peri-implantitis at 12 months following loading will be the primary outcome variable of the study. The proportion of patients with complete resolution of the bone dehiscence (BD), dimensional variations and 12-months characteristics of BD, and patient-reported outcome measures will be the secondary outcomes. The design will test two hypotheses, with a non-inferiority trial in terms of primary outcome and a superiority trial in terms of secondary outcomes.

Registry
clinicaltrials.gov
Start Date
July 1, 2022
End Date
December 31, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Università degli Studi di Ferrara
Responsible Party
Principal Investigator
Principal Investigator

Leonardo Trombelli

Full Professor and Chair of Periodontology

Università degli Studi di Ferrara

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Proportion of patients free from peri-implantitis

Time Frame: 12-month visit

Proportion of patients free from peri-implantitis (diagnosed according to the criteria described by Berglundh et al. 2018) at 12 months following loading

Secondary Outcomes

  • Complete resolution of bone dehiscence (BD)(12-month visit)
  • Changes in height and width of bone dehiscence (BD)(Pre-surgery and 12-month visits)
  • Height and width of the residual bone dehiscence (BD)(12-month visit)
  • Pain(Day 0, +1, +2, +3, +4, +7 and +14 following surgery)
  • Dose of rescue anti-inflammatory drug(First 14 days following surgery)
  • Discomfort(Day 0, +1, +2, +3, +4, +7 and +14 following surgery)
  • Limitations in daily functions(Day 0, +1, +2, +3, +4, +7 and +14 following surgery)
  • Incidence of postoperative signs and symptoms(Day 0, +1, +2, +3, +4, +7 and +14 following surgery)
  • Willingness to undergo the same type of surgery(Day +14 following surgery)

Study Sites (1)

Loading locations...

Similar Trials